Somapacitan in children born small for gestational age: 4-year results from phase 2

Anders Juul, Michael Højby, Masanobu Kawai, Agnès Linglart, Jun Mori, Nehama Zuckerman-Levin, Philippe Backeljauw

Open source

DOI
10.1093/ejendo/lvag017
Published
2026-01-30
Container
European Journal of Endocrinology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag017,
  title = {Somapacitan in children born small for gestational age: 4-year results from phase 2},
  author = {Anders Juul and Michael Højby and Masanobu Kawai and Agnès Linglart and Jun Mori and Nehama Zuckerman-Levin and Philippe Backeljauw},
  year = {2026},
  journal = {European Journal of Endocrinology},
  doi = {10.1093/ejendo/lvag017},
  url = {https://doi.org/10.1093/ejendo/lvag017}
}

RIS

TY  - JOUR
TI  - Somapacitan in children born small for gestational age: 4-year results from phase 2
AU  - Anders Juul
AU  - Michael Højby
AU  - Masanobu Kawai
AU  - Agnès Linglart
AU  - Jun Mori
AU  - Nehama Zuckerman-Levin
AU  - Philippe Backeljauw
PY  - 2026
JO  - European Journal of Endocrinology
DO  - 10.1093/ejendo/lvag017
UR  - https://doi.org/10.1093/ejendo/lvag017
ER  - 

APA

Juul, A., Højby, M., Kawai, M., Linglart, A., Mori, J., Zuckerman-Levin, N., & Backeljauw, P. (2026). Somapacitan in children born small for gestational age: 4-year results from phase 2. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag017

Source records